Seth Michelson – författare

The first book to focus on comprehensive systems biology as applied to drug discovery and development Drawing on real-life examples, Systems Biology in Drug Discovery and Development presents practical applications of systems biology to the multiple phases of drug discovery and development. This book explains how the integration of knowledge from multiple sources, and the models that best represent that integration, inform the drug research processes that are most relevant to the pharmaceutical and biotechnology industries.The first book to focus on comprehensive systems biology and its applications in drug discovery and development, it offers comprehensive and multidisciplinary coverage of all phases of discovery and design, including target identification and validation, lead identification and optimization, and clinical trial design and execution, as well as the complementary systems approaches that make these processes more efficient. It also provides models for applying systems biology to pharmacokinetics, pharmacodynamics, and candidate biomarker identification.Introducing and explaining key methods and technical approaches to the use of comprehensive systems biology on drug development, the book addresses the challenges currently facing the pharmaceutical industry. As a result, it is essential reading for pharmaceutical and biotech scientists, pharmacologists, computational modelers, bioinformaticians, and graduate students in systems biology, pharmaceutical science, and other related fields.

The first book to focus on comprehensive systems biology as applied to drug discovery and development

Drawing on real-life examples, Systems Biology in Drug Discovery and Development presents practical applications of systems biology to the multiple phases of drug discovery and development. This book explains how the integration of knowledge from multiple sources, and the models that best represent that integration, inform the drug research processes that are most relevant to the pharmaceutical and biotechnology industries.

The first book to focus on comprehensive systems biology and its applications in drug discovery and development, it offers comprehensive and multidisciplinary coverage of all phases of discovery and design, including target identification and validation, lead identification and optimization, and clinical trial design and execution, as well as the complementary systems approaches that make these processes more efficient. It also provides models for applying systems biology to pharmacokinetics, pharmacodynamics, and candidate biomarker identification.

Introducing and explaining key methods and technical approaches to the use of comprehensive systems biology on drug development, the book addresses the challenges currently facing the pharmaceutical industry. As a result, it is essential reading for pharmaceutical and biotech scientists, pharmacologists, computational modelers, bioinformaticians, and graduate students in systems biology, pharmaceutical science, and other related fields.

The first book to focus on comprehensive systems biology as applied to drug discovery and development

Drawing on real-life examples, Systems Biology in Drug Discovery and Development presents practical applications of systems biology to the multiple phases of drug discovery and development. This book explains how the integration of knowledge from multiple sources, and the models that best represent that integration, inform the drug research processes that are most relevant to the pharmaceutical and biotechnology industries.

The first book to focus on comprehensive systems biology and its applications in drug discovery and development, it offers comprehensive and multidisciplinary coverage of all phases of discovery and design, including target identification and validation, lead identification and optimization, and clinical trial design and execution, as well as the complementary systems approaches that make these processes more efficient. It also provides models for applying systems biology to pharmacokinetics, pharmacodynamics, and candidate biomarker identification.

Introducing and explaining key methods and technical approaches to the use of comprehensive systems biology on drug development, the book addresses the challenges currently facing the pharmaceutical industry. As a result, it is essential reading for pharmaceutical and biotech scientists, pharmacologists, computational modelers, bioinformaticians, and graduate students in systems biology, pharmaceutical science, and other related fields.

From an award-winning poet comes a humanizing story of immigration shown through the lens of undocumented, unaccompanied children and the poems they write.“Heartfelt . . . a surprisingly uplifting call to reform an unjust system.” –Publishers WeeklyIn heart-wrenching prose, Seth Michelson faces the U.S. immigration crisis head on—by learning and sharing the stories of migrating people fleeing violence and poverty, and by leading workshops for minors held inside a maximum-security detention center. Highlighting the experiences of people desperate for safety, Michelson tirelessly fights for justice and their freedom. Guided through the powerful medium of poetry, the children share their pasts, struggles, hopes, and dreams. Among them, Carlitos, a 13-year-old boy who escaped a gang to try to make a safe and honest life on his own after his mother’s death, and Karla, a teenager whose family begged her to flee for safety after she was shot. Remarkably, they and other children from similar circumstances express themselves with honesty, passion, and optimism for a better future. Michelson also introduces us to migrating people at the border, including a woman who was chased from her home amid violence, and a dedicated father who was arrested and beaten while searching for work to make a more secure life for his wife and daughter. Whether relating experiences in a Mexican refugee camp or a U.S. immigration detention center, Michelson’s prose is brisk and gripping, offering hard-earned insights into ways we might create a better immigration system that treats all people with dignity.

A powerful work of narrative nonfiction that humanizes the immigration crisis in the United States through the lens of undocumented, unaccompanied minors and the teacher who provides hope through poetry. With unprecedented access, poet Seth Michelson takes readers inside the most restrictive maximum security detention center in the United States, where undocumented, unaccompanied youth are held in isolation. As the reader meets several children who are part of the author’s poetry workshop, we hear from the children in their own words, and learn the harsh reality of the lived experiences of migrating people who are trying to escape violence and poverty in their home countries. Their pasts, their struggles, their hopes, and their dreams are highlighted through the medium of poetry. The author shares these stories, as well as those of mothers and children at a different facility in Dilley, Texas, infamous site of the death of 20-month old Mariee Juarez, whose death made front page headlines in 2018. Each chapter is grounded in the voices of migrating people from El Salvador, Honduras, Mexico, and Cuba. Through these stories, the reader learns the intricacies of our immigration system and the challenges migrants face as they work toward a better life. Armed with this knowledge, readers may be inspired to act on behalf of these powerless children, whether by implementing a model poetry workshop in their own community or working with advocacy groups or legal aid groups to champion for change.

The US is currently well ahead of the rest of the world in the development and application of SB and its principles especially as they pertain to basic medical research and development. This lead is largely due to its earlier start in the academic arena. However, there is evidence of rapid development in both the UK/EU and Japan, and the gap is narrowing, particularly in the UK. From an industrial point of view, the Pharmaceutical Industry based in the US and UK can capitalize on these opportunities and gain the benefits of this technology. Many educational institutions (particularly their medical divisions) at present are heavily business-oriented, realize that in this particular industrial environment, that every dollar counts.